In a 75-year-old patient with acute otitis media, should amoxicillin be capped at the standard adult dose of 875 mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Amoxicillin Dosing for AOM: Do Not Cap at 875 mg in Adults

For acute otitis media in a 75-year-old patient, amoxicillin should NOT be arbitrarily capped at 875 mg—the standard adult dose of 1500-4000 mg/day (divided twice daily) applies regardless of age, with higher doses (up to 4000 mg/day) recommended for patients at risk of resistant pathogens.

Rationale for Standard Adult Dosing

The evidence consistently supports weight-based or fixed adult dosing without arbitrary caps:

  • FDA labeling confirms that standard adult amoxicillin dosing is 1500 mg/day (500 mg three times daily or 875 mg twice daily) for routine infections, with the 875 mg tablet producing therapeutic levels 1

  • Acute bacterial rhinosinusitis guidelines (which share similar pathogens with AOM) recommend 1.5-4 g/day for adults, with higher doses (4 g/day) specifically indicated for patients at risk of resistant Streptococcus pneumoniae or those with recent antibiotic exposure 2

  • The 875 mg twice daily formulation (1750 mg/day total) is a standard FDA-approved adult dose that should not be considered a "cap" but rather one dosing option 1

When to Use Higher Doses (Up to 4000 mg/day)

High-dose amoxicillin (4 g/day) is specifically recommended for adults with:

  • Recent antibiotic use within 4-6 weeks 2
  • Moderate disease severity 2
  • High local prevalence of penicillin-resistant S. pneumoniae 2
  • Risk factors for resistant pathogens 2

This 75-year-old patient likely falls into one or more of these categories, making the standard 875 mg twice daily (1750 mg/day) appropriate, with consideration for higher doses if risk factors are present.

Pediatric Context Does Not Apply to Adults

The confusion about "capping" doses likely stems from pediatric guidelines where weight-based dosing (80-90 mg/kg/day) can theoretically exceed adult doses in heavier children 3, 4, 5. However:

  • This concern is irrelevant for adults, where fixed dosing regimens of 1500-4000 mg/day are standard 2
  • Research shows that even in obese children, many clinicians inappropriately cap doses at adult levels, which is not recommended 5
  • The adult dose range is established based on pharmacokinetics and efficacy data, not arbitrary weight cutoffs 1

Practical Dosing Algorithm for This Patient

For a 75-year-old with uncomplicated AOM:

  1. First-line: Amoxicillin 875 mg twice daily (1750 mg/day) for 5-10 days 3, 4
  2. If recent antibiotics or risk factors: Consider amoxicillin 1000 mg three times daily (3000 mg/day) or amoxicillin-clavulanate 2000/125 mg twice daily 2
  3. If treatment failure at 48-72 hours: Switch to amoxicillin-clavulanate or respiratory fluoroquinolone 2

Renal Adjustment Is the Only True "Cap"

The only legitimate reason to reduce amoxicillin dosing in this elderly patient is renal impairment:

  • GFR <30 mL/min: Reduce dose by 50% or extend dosing interval 1
  • Severe renal impairment (GFR <10 mL/min): Maximum 500 mg every 24 hours 1

Without documented renal dysfunction, standard adult dosing (1500-4000 mg/day) should be used without arbitrary caps at 875 mg.

Common Pitfall to Avoid

Do not confuse the 875 mg tablet strength with a maximum daily dose. The 875 mg formulation is designed for twice-daily dosing (1750 mg/day total), which is within the standard adult range. Higher total daily doses can be achieved using 500 mg tablets three or four times daily if clinically indicated 2.

References

Guideline

antimicrobial treatment guidelines for acute bacterial rhinosinusitis.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.